Ignite Creation Date:
2024-05-05 @ 9:39 PM
Last Modification Date:
2024-10-26 @ 10:08 AM
Study NCT ID:
NCT00939770
Status:
COMPLETED
Last Update Posted:
2020-06-09
First Post:
2009-07-14
Brief Title:
Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Organization Data
Organization:
Childrens Oncology Group
Class:
NETWORK
Study ID:
ADVL0912
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |
| National Cancer Institute NCI | NIH |